Archive for the ‘japan retractions’ Category
We imagine readers of Biomedical Chromatography’s special issue, “Reminiscences of Chang Kee Lim,” did some flipping back and forth when they found the same paper published twice.
Here’s the resulting notice for “Determination of 4-hydroxy-2-nonenal in serum by high-performance liquid chromatography with fluorescence detection after pre-column derivatization using 4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole”: Read the rest of this entry »
The Japanese endocrinology researcher Shigeaki Kato, with at least 25 retractions to his name, is alleged to have been the ringleader of a scheme to cover up other research misconduct at the University of Tokyo, his former employer, which investigated the activity.
In a stunning and tragic development, a co-author of the now-retracted Nature papers claiming to have found an easy way to create stem cells has committed suicide, according to news reports in Japan.
A paper about a protein being used — unapproved by health agencies — to treat diseases including cancer and autism has been retracted.
Publishing gadfly demands journal editor’s resignation, then has “fairly incomprehensible” paper rejected
A scientific publishing gadfly who was banned earlier this year from an Elsevier journal for “personal attacks and threats” has had a paper rejected by a Springer journal after he called for the editor’s resignation because of alleged incompetence.
As detailed in a comment left at Retraction Watch, Jaime A. Teixeira da Silva submitted a manuscript titled “One Conjunction, a World of Ethical Difference: How Elsevier, the ICMJE and Neurology Define Authorship” to Science and Engineering Ethics on November 11, 2012. As of last week, despite a number of messages sent to editors of the journal, he had not had a decision on the manuscript.
As a result, on July 14 of this year, Teixeira da Silva sent this letter to journal editor Raymond Spier and to Stephanie Bird, an editorial board member assigned to the manuscript: Read the rest of this entry »
STAP stem cell papers officially retracted as Nature argues peer review couldn’t have detected fatal problems
A significant chapter of the nearly six-month saga of the STAP stem cell controversy has come to an end, with Nature running retraction notices for the two papers involved. The journal has also published an editorial about the case that’s worth a read.
The retractions for “Bidirectional developmental potential in reprogrammed cells with acquired pluripotency” and “Stimulus-triggered fate conversion of somatic cells into pluripotency” both read: Read the rest of this entry »